ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 157995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 157995; 2) Community: the network communities that were significantly associated with the response to NSC 157995; 3) Molecule: the relationships between components within communities and NSC 157995; 4) MDR: the compounds that were significantly associated with the NSC 157995.

NSC Compound Enrichment Correlation
NSC 117187 Indole-2,3-dione, 5,7-dichloro-, 3-[(o-nitrophenyl) hydrazone] 0.0152777849043087 0.31484061
NSC 30915 Null 0.0164116791870036 -0.12331481
NSC 313681 Oxiperomide(USAN) 0.0164116791870036 -0.076182523
NSC 606499 Camptothecin Derivative 0.0164116791870036 0.32373275
NSC 631371 N-(3,5-Dimethoxybenzyl)-4-methoxyaniline 0.0164116791870036 -0.09726975
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0164116791870036 -0.096067644
NSC 681632 Camptothecin Derivative 0.0164116791870036 0.34612846
NSC 683517 8H-Thieno[2,3-b]pyrrolizinium, 3-(4-bromophenyl)-4-methyl- 8-(1-pyrrolidinyl)-, iodide 0.0164116791870036 0.45661208
NSC 683556 Camptothecin Derivative 0.0164116791870036 0.37647791
NSC 700363 Liposomal Annamycin 0.0164116791870036 0.21974107
Total:54  Current:16    [First] [Prev] [Next] [Last]